[go: up one dir, main page]

AR038552A2 - Analogos proteicos relacionados con la hormona paratiroides - Google Patents

Analogos proteicos relacionados con la hormona paratiroides

Info

Publication number
AR038552A2
AR038552A2 ARP030100515A ARP030100515A AR038552A2 AR 038552 A2 AR038552 A2 AR 038552A2 AR P030100515 A ARP030100515 A AR P030100515A AR P030100515 A ARP030100515 A AR P030100515A AR 038552 A2 AR038552 A2 AR 038552A2
Authority
AR
Argentina
Prior art keywords
acc
cha
aib
leu
lys
Prior art date
Application number
ARP030100515A
Other languages
English (en)
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Publication of AR038552A2 publication Critical patent/AR038552A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Análogos proteicos relacionados con la hormona paratiroides, que comprende la fórmula (R1R2)A1-Val-A3-Glu-A5-Gln-A7-A8-His-A10-A11-A12-Lys-A14-A15-A16-A17-A18-A19-Arg-Arg-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-R3 donde: A1 es Ala, Ser o Dap; A3 es Ser, o Aib; A5 es His, Ile, Acc, o Cha; A7 es Leu, Cha, Nle, b-Nal, Trp, Pal, Acc, Phe o p-X-Phe, donde X es OH, un halógeno o CH3; A8 es Leu, Met, Acc, o Cha; A10 es Asp o Asn; A11 es Lys, Leu, Cha, Acc, Phe, o b-Nal; A12 es Gly, Acc, o Aib; A14 Ser o His; A15 es Ile, Acc, o Cha; A16 es Gln o Aib; A17 es Asp o Aib; A18 es Leu, Aib, Acc, o Cha; A19 es Arg o Aib; A22 es Phe, Glu, Aib, Acc o Cha; A23 es Phe, Leu, Lys, Acc o Cha; A24 es Leu, Lys, Acc o Cha; A25 es His, Lys, Aib, Acc o Glu; A26 es His, Aib, Acc o Lys; A27 es Leu, Lys, Acc o Cha; A28 es Ile, Leu, Lys, Acc o Cha; A29 es Ala, Glu, Acc o Aib; A30 es Glu, Leu, Nle, Cha, Aib, Acc, o Lys; A31 es Ile, Leu, Cha, Lys, Acc o está suprimido; A32 es His o está suprimido; A33 es Thr o está suprimido; A34 es Ala o está suprimido; cada uno de R1 o R2, es, en forma independiente, H, alcanilo C1-12, fenilalquilo C7-20, naftilalquilo C11-20, hidroxialquilo C1-12; hidroxialquenilo C2-12; hidrofenilalquilo C7-20; hidroxinaftilalquilo C11-20; o uno y solamente uno de R1 y R2 es COE1, donde E1 es alquilo C1-12; alquilo C2-12; alquenilo C2-12; fenilalquilo C7-20; naftilalquilo C11-20, hidroxialquilo C1-12; hidroxialquenilo C2-12; hidroxifenilalquilo C7-20; o hidroxinaftilalquilo C11-20; y R3 es OH, NH2, alcoxi C1-12; o NH-Y-CH2-Z, donde Y, es una porción de hidrocarburo C1-12; y Z es H, OH, CO2H, o CONH2; siempre que la menos uno de A5, A7, A8, A11, A12, A15, A18, A22, A23, A24, A25, A26, A27, A28, A29, A30, o A31, sea Acc; o una sal farmacéuticamente aceptable de los mismos.
ARP030100515A 1997-01-07 2003-02-17 Analogos proteicos relacionados con la hormona paratiroides AR038552A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone

Publications (1)

Publication Number Publication Date
AR038552A2 true AR038552A2 (es) 2005-01-19

Family

ID=27119618

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980100058A AR011517A1 (es) 1997-01-07 1998-01-06 Analogos proteicos relacionados con la hormona paratiroides
ARP030100515A AR038552A2 (es) 1997-01-07 2003-02-17 Analogos proteicos relacionados con la hormona paratiroides
ARP060100191A AR051906A2 (es) 1997-01-07 2006-01-18 Analogos proteicos relacionados con la hormona paratiroides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980100058A AR011517A1 (es) 1997-01-07 1998-01-06 Analogos proteicos relacionados con la hormona paratiroides

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP060100191A AR051906A2 (es) 1997-01-07 2006-01-18 Analogos proteicos relacionados con la hormona paratiroides

Country Status (24)

Country Link
US (1) US5955574A (es)
EP (3) EP1645566B1 (es)
JP (1) JP3963482B2 (es)
KR (2) KR100497709B1 (es)
CN (1) CN1137898C (es)
AR (3) AR011517A1 (es)
AT (2) ATE471342T1 (es)
AU (1) AU741584B2 (es)
BR (1) BR9714200A (es)
CA (1) CA2276614C (es)
CZ (2) CZ301497B6 (es)
DE (2) DE69735603T2 (es)
DK (2) DK1645566T3 (es)
ES (2) ES2258286T3 (es)
HK (1) HK1026215A1 (es)
HU (1) HUP9904596A3 (es)
IL (1) IL130794A0 (es)
NO (1) NO993341L (es)
NZ (1) NZ336610A (es)
PL (1) PL191898B1 (es)
PT (2) PT1645566E (es)
RU (1) RU2198182C2 (es)
SI (2) SI0948541T1 (es)
WO (1) WO1998030590A2 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
JP2002509854A (ja) 1997-09-09 2002-04-02 エフ.ホフマン−ラ ロシュ アーゲー PTHrP類似体を使用する骨折治癒
HUP0300891A2 (hu) * 1998-05-05 2003-07-28 Beth Israel Deaconess Medical Center, Inc. PTH2 receptor szelektív vegyületek és alkalmazásuk gyógyszerkészítmények előállÍtására
DE69941708D1 (de) * 1998-07-20 2010-01-07 Ipsen Pharma Pacap-peptidanaloga
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001060862A1 (en) 2000-02-18 2001-08-23 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
MXPA03011027A (es) 2001-06-01 2004-03-19 Novartis Ag Administracion oral de hormona paratiroides y calcitonina.
CA2454275C (en) 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
KR20060056975A (ko) * 2003-08-06 2006-05-25 로디아 인코포레이티드 뼈 성장 촉진방법
AU2006315132A1 (en) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
CN102274492B (zh) * 2006-10-03 2014-11-26 半径健康公司 骨合成代谢蛋白质的药物递送方法
WO2008048784A1 (en) * 2006-10-13 2008-04-24 Eli Lilly And Company Pegylated pth as pth receptor modulators and uses thereof
EP2187902B1 (en) 2007-08-01 2013-04-17 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
US8563513B2 (en) 2009-03-27 2013-10-22 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
EP2509996A1 (en) 2009-12-07 2012-10-17 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
MX342898B (es) 2010-05-12 2016-10-18 Radius Health Inc * Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol.
US9492508B2 (en) 2010-05-13 2016-11-15 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
JP5965909B2 (ja) 2010-09-28 2016-08-10 ラジウス ヘルス,インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
SG11201708858WA (en) 2015-04-29 2017-11-29 Radius Pharmaceuticals Inc Methods of treating cancer
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
SG11201811225RA (en) 2016-06-22 2019-01-30 Radius Health Inc Ar+ breast cancer treatment methods
JP7481115B2 (ja) 2017-01-05 2024-05-10 ラジウス ファーマシューティカルズ,インコーポレイテッド Rad1901-2hclの多形性形態
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
AU2019297421B2 (en) 2018-07-04 2024-08-29 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD 1901-2HCL

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (en) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
EP0411096A1 (de) * 1989-02-23 1991-02-06 Gesellschaft für Biotechnologische Forschung mbH (GBF) Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1993006846A1 (en) * 1991-10-10 1993-04-15 Pang Peter K T Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
NZ261250A (en) 1993-01-06 1997-08-22 Kinerton Ltd Ionic conjugates of polypeptides
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
WO1996019246A1 (en) * 1994-12-19 1996-06-27 Beth Israel Hospital Association Continuous low-dose administration of parathyroid hormone or its agonist
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
EP1645566B1 (en) 2010-06-16
DE69739912D1 (de) 2010-07-29
AU5519998A (en) 1998-08-03
CA2276614A1 (en) 1998-07-16
WO1998030590A9 (en) 1999-08-19
AU741584B2 (en) 2001-12-06
CA2276614C (en) 2002-06-11
AR051906A2 (es) 2007-02-14
EP2206725A1 (en) 2010-07-14
PL334438A1 (en) 2000-02-28
AR011517A1 (es) 2000-08-30
IL130794A0 (en) 2001-01-28
RU2198182C2 (ru) 2003-02-10
EP1645566A3 (en) 2006-10-11
PT1645566E (pt) 2010-08-31
KR100497709B1 (ko) 2005-06-23
JP3963482B2 (ja) 2007-08-22
JP2001508439A (ja) 2001-06-26
CZ298937B6 (cs) 2008-03-19
HUP9904596A3 (en) 2000-07-28
ES2347154T3 (es) 2010-10-26
CN1137898C (zh) 2004-02-11
SI0948541T1 (sl) 2006-06-30
SI1645566T1 (sl) 2010-11-30
CN1254347A (zh) 2000-05-24
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
KR100699422B1 (ko) 2007-03-28
DK0948541T3 (da) 2006-07-17
DE69735603T2 (de) 2006-11-30
KR20000069952A (ko) 2000-11-25
HUP9904596A1 (hu) 2000-06-28
BR9714200A (pt) 2000-03-28
ATE321784T1 (de) 2006-04-15
EP0948541A2 (en) 1999-10-13
WO1998030590A3 (en) 1998-12-10
KR20060030006A (ko) 2006-04-07
WO1998030590A2 (en) 1998-07-16
EP1645566A2 (en) 2006-04-12
CZ301497B6 (cs) 2010-03-24
ES2258286T3 (es) 2006-08-16
US5955574A (en) 1999-09-21
NZ336610A (en) 2001-07-27
DK1645566T3 (da) 2010-09-27
EP0948541B1 (en) 2006-03-29
PT948541E (pt) 2006-07-31
HK1026215A1 (en) 2000-12-08
NO993341L (no) 1999-09-06
DE69735603D1 (de) 2006-05-18
CZ239899A3 (cs) 2000-01-12
ATE471342T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
AR038552A2 (es) Analogos proteicos relacionados con la hormona paratiroides
Pepinsky et al. Identification of a palmitic acid-modified form of human Sonic hedgehog
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
HUP0104579A2 (hu) GLP-1 analógok, ezeket tartalmazó gyógyászati készítmények, valamint a vegyületek alkalmazása
HUP0002869A2 (hu) Benzotiofén-karboxamid-származékok, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
HUP9801886A2 (hu) Eljárás megfelelően kapcsolódó cisztinhidakat tartalmazó inzulin-prekurzorok előállítására
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
TW200626613A (en) Analogues of GLP-1
HUP9901209A2 (hu) Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DE69803750D1 (de) Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften
ATE228360T1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
BR9707064A (pt) Novos derivados 19-nor-pregneno
DE69938064D1 (de) Aminoterminal modifizierte parathyroidhormon (pth) analoge
NO995928L (no) Alfa-1-antitrypsin-preparater samt fremgangsmåte ved fremstilling derav
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
KR920014777A (ko) 치환된1,2,3,4-테트라하이드로사이클로펜트[b]인돌 1,2,3,3a,4,8a-헥사하이드로사이클로펜트[b]인돌 및 관련 화합물, 이의 중간체 및 제조방법 및 약제로서의 이의용도
BR9905732A (pt) Processo e intermediários para secretagogos do hormÈnio do crescimento
HUP0105308A2 (hu) Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények
HUP9901212A2 (hu) N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk
DE69333660D1 (de) Pct-65 serotonin rezeptor
KR950701341A (ko) 불소화된 4-아미노안드로스타디에논 유도체 및 이들의 제조방법(Fluorinated 4-aminoandrostadienone derivatives and process for their preparation)
HUP0004565A2 (hu) Szubsztituált krománszármazékok, intermedierjeik és azokat tartalmazó gyógyszerkészítmények
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.

Legal Events

Date Code Title Description
FG Grant, registration